ClinConnect ClinConnect Logo
Search / Trial NCT05878665

Low-dose Contrast Media for Low-kVp Abdomen CT

Launched by BOHYUN KIM · May 18, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Acute Appendicitis Acute Abdomen Ct

ClinConnect Summary

This clinical trial is looking at a new way to diagnose acute appendicitis, which is an inflammation of the appendix that can be serious if not treated quickly. The researchers want to see if using a lower amount of radiation during a CT scan, along with a smaller dose of contrast media (a special dye used to improve the images), can still provide accurate results. This approach aims to reduce the radiation exposure for young patients while still being effective in identifying appendicitis.

To be eligible for this study, participants must be young patients in the emergency department who have symptoms suggesting acute appendicitis and are scheduled for a CT scan of their abdomen and pelvis. However, individuals who are pregnant, have certain kidney issues, or have a high body mass index (BMI) won't be able to participate. If you or someone you know is eligible, the trial will involve undergoing a CT scan with lower doses of both radiation and contrast media, and you will help researchers understand if this method is both safe and effective.

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • Patients in the emergency department with suspected acute appendicitis based on clinical examination
  • Patients scheduled for contrast-enhanced CT of the abdomen and pelvis for diagnosis of suspected acute appendicitis.
  • Exclusion criteria:
  • Patients who decline to participate
  • Contraindications to contrast-enhanced CT (eGFR \< 30 mL/min/173 m\^2 or pregnant)
  • BMI \>= 30.

About Bohyun Kim

Bohyung Kim is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous methodologies. With a focus on ethical practices and regulatory compliance, Bohyung Kim collaborates with healthcare professionals and research institutions to facilitate the development of novel therapies and treatments. By leveraging cutting-edge technology and a patient-centered approach, Bohyung Kim aims to enhance the efficiency and effectiveness of clinical trials, ensuring that scientific advancements translate into meaningful healthcare solutions.

Locations

Seoul, , Korea, Republic Of

Patients applied

0 patients applied

Trial Officials

Bohyun Kim, MD, PhD

Principal Investigator

Seoul St. Mary's Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported